Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07129226 · ClinicalTrials.gov registry record · NA
Musculoskeletal Cancers Remote Monitoring and Care
A NA study of Osteosarcoma and Metastatic Bone Disease, sponsored by Case Comprehensive Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT07129226 is a NA study of Osteosarcoma and Metastatic Bone Disease that is actively recruiting participants, run by Case Comprehensive Cancer Center. The registered enrollment target is 60 participants, below the 300-participant average among 46 other Osteosarcoma trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07129226, a NA study of Osteosarcoma and Metastatic Bone Disease, is actively recruiting participants, sponsored by Case Comprehensive Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to evaluate how walking stability and the ability to perform daily activities change during cancer treatment, and whether a smartwatch can detect these changes. The goal is to develop proactive, personalized tools that automatically monitor treatment response and predict potential complications. To support future implementation, the study will assess the feasibility of wearing a smartwatch for at least 12 hours per day, using a mobile application, and completing weekly questionnaires among patients with primary osteosarcoma or metastatic bone disease.
Conditions Studied
Interventions
- OTHER Smart Watch
Study Locations (1)
Ohio
- Case Comprehensive Cancer Center, Cleveland Clinic Foundation - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-02-11 |
| Est. Completion | 2026-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07129226
The ClinicalTrials.gov registry entry for NCT07129226 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 300-participant average among 46 other Osteosarcoma trials with a reported enrollment target (80% lower). The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Osteosarcoma appearing as the primary indexed condition, and to 1 intervention - of which Smart Watch is the first listed.
NCT07129226 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT07129226 about?
NCT07129226 is a clinical study titled "Musculoskeletal Cancers Remote Monitoring and Care". This study aims to evaluate how walking stability and the ability to perform daily activities change during cancer treatment, and whether a smartwatch can detect these changes. The goal is to develop proactive, personalized tools that automatically monitor treatment response and predict potential co...
What is the current status of trial NCT07129226?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-02-11. Estimated completion is 2026-08.
What conditions does trial NCT07129226 study?
This clinical trial studies the following conditions: Osteosarcoma, Metastatic Bone Disease.
What interventions are being tested in trial NCT07129226?
The interventions under investigation include: Smart Watch (OTHER).
Who is sponsoring clinical trial NCT07129226?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07129226 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteosarcoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning
RECRUITING · NA
-
Chemotherapy Resistance in Osteogenic Sarcoma and Other Solid Tumors
ACTIVE NOT RECRUITING · NA
-
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RECRUITING · Phase 1
-
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
RECRUITING · Phase 1
-
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
RECRUITING · Phase 1
-
Losartan + Sunitinib in Treatment of Osteosarcoma
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.